Innate Pharma Financial Flexibility Index
Innate Pharma financial flexibility index. Innate Pharma (IPH) has a Financial Flexibility Index of -0.25x as of December 2025. Free cash flow of €-21.51 Million (operating CF €-21.59 Million minus capex €82.00K) represents 0% of total liabilities (€84.42 Million). See cash generation quality of Innate Pharma to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Innate Pharma (2005–2025)
Financial flexibility index of Innate Pharma from 2005 to 2025. Historical Financial Flexibility Index trend for Innate Pharma across 21 annual periods. Check IPH operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Innate Pharma Financial Flexibility Index by Year (2005–2025)
Innate Pharma financial flexibility index by year from 2005 to 2025. Year-by-year free cash flow to debt coverage for Innate Pharma. For the full cash flow conversion analysis, see how efficiently does Innate Pharma generate cash.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.62x | €-52.62 Million | €-52.76 Million | €84.42 Million | ▼ -879.4% |
| 2024 | -0.06x | €-6.50 Million | €-6.90 Million | €102.22 Million | ▲ +72.1% |
| 2023 | -0.23x | €-30.21 Million | €-32.56 Million | €132.29 Million | ▼ -94.6% |
| 2022 | -0.12x | €-18.03 Million | €-19.15 Million | €153.71 Million | ▲ +67.1% |
| 2021 | -0.36x | €-57.13 Million | €-58.46 Million | €160.06 Million | ▼ -33.4% |
| 2020 | -0.27x | €-40.52 Million | €-51.81 Million | €151.45 Million | ▼ -149.1% |
| 2019 | 0.55x | €100.33 Million | €34.92 Million | €183.94 Million | ▲ +598.0% |
| 2018 | -0.11x | €-31.10 Million | €-32.53 Million | €283.98 Million | ▲ +55.9% |
| 2017 | -0.25x | €-42.03 Million | €-48.06 Million | €169.07 Million | ▼ -76.9% |
| 2016 | -0.14x | €-27.46 Million | €-36.85 Million | €195.41 Million | ▼ -115.3% |
| 2015 | 0.92x | €215.31 Million | €207.91 Million | €233.89 Million | ▲ +193.6% |
| 2014 | -0.98x | €-15.79 Million | €-18.13 Million | €16.06 Million | ▼ -45.5% |
| 2013 | -0.68x | €-10.53 Million | €-10.97 Million | €15.60 Million | ▼ -82.0% |
| 2012 | -0.37x | €-9.25 Million | €-10.47 Million | €24.93 Million | ▼ -193.4% |
| 2011 | 0.40x | €13.31 Million | €12.99 Million | €33.48 Million | ▲ +144.2% |
| 2010 | -0.90x | €-13.04 Million | €-13.45 Million | €14.49 Million | ▼ -183.6% |
| 2009 | -0.32x | €-5.42 Million | €-5.94 Million | €17.10 Million | ▲ +51.8% |
| 2008 | -0.66x | €-12.84 Million | €-14.74 Million | €19.52 Million | ▼ -11.6% |
| 2007 | -0.59x | €-7.99 Million | €-9.28 Million | €13.55 Million | ▼ -783.1% |
| 2006 | 0.09x | €1.11 Million | €360.00K | €12.89 Million | ▲ +105.7% |
| 2005 | -1.52x | €-7.14 Million | €-7.25 Million | €4.70 Million | — |